DE602005017812D1 - Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit - Google Patents

Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit

Info

Publication number
DE602005017812D1
DE602005017812D1 DE602005017812T DE602005017812T DE602005017812D1 DE 602005017812 D1 DE602005017812 D1 DE 602005017812D1 DE 602005017812 T DE602005017812 T DE 602005017812T DE 602005017812 T DE602005017812 T DE 602005017812T DE 602005017812 D1 DE602005017812 D1 DE 602005017812D1
Authority
DE
Germany
Prior art keywords
stem cells
ischemic
multipotent stem
treatment
multipotential
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017812T
Other languages
English (en)
Inventor
Kyung Sun Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seoul National University Industry Foundation
Original Assignee
Seoul National University Industry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seoul National University Industry Foundation filed Critical Seoul National University Industry Foundation
Publication of DE602005017812D1 publication Critical patent/DE602005017812D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
DE602005017812T 2005-08-26 2005-08-26 Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit Active DE602005017812D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/002834 WO2007024036A1 (en) 2005-08-26 2005-08-26 Multipotent stem cells isolated from umbilical cord blood and the cellular therapeutic agent comprisin the same for treating ischemic disease

Publications (1)

Publication Number Publication Date
DE602005017812D1 true DE602005017812D1 (de) 2009-12-31

Family

ID=37771760

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017812T Active DE602005017812D1 (de) 2005-08-26 2005-08-26 Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit

Country Status (7)

Country Link
US (1) US20070110727A1 (de)
EP (1) EP1807509B1 (de)
JP (1) JP2007528229A (de)
AT (1) ATE449165T1 (de)
DE (1) DE602005017812D1 (de)
ES (1) ES2336230T3 (de)
WO (1) WO2007024036A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10281478B2 (en) * 2000-04-06 2019-05-07 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법
WO2010027195A2 (ko) * 2008-09-05 2010-03-11 Lee Sung Min 녹용유래세포 및 이의 배양방법
US8796315B2 (en) 2009-06-25 2014-08-05 Darlene E. McCord Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells
EP2524034A1 (de) * 2010-01-14 2012-11-21 Organogenesis, Inc. Biotechnologisch hergestellte gewebekonstrukte sowie verfahren zu ihrer herstellung und verwendung
US8940294B2 (en) 2012-03-02 2015-01-27 Tissuetech, Inc. Methods of isolating and culturing stem cells
CA2892375A1 (en) 2012-11-30 2014-06-05 Darlene E. MCCORD Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition
TWI825446B (zh) * 2020-08-14 2023-12-11 中國醫藥大學 醫藥組合物治療組織缺血狀況之用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560280B2 (en) * 2000-11-03 2009-07-14 Kourion Therapeutics Gmbh Human cord blood derived unrestricted somatic stem cells (USSC)
EP1482787A4 (de) * 2002-02-13 2006-02-15 Anthrogenesis Corp Embryoartige stammzellen aus der post partum plazenta von säugetieren sowie anwendungszwecke und behandlungsverfahren, bei denen diese zellen verwendet werden
CN1281739C (zh) * 2002-02-19 2006-10-25 美迪宝斯特有限公司 从脐带血中分离并扩大培养间充质干细胞/祖细胞及将脐带血来源的间充质干细胞/祖细胞分化成各种间充质组织的方法
US20040203142A1 (en) * 2003-04-14 2004-10-14 Reliance Life Sciences Pvt. Ltd. Growth of neural precursor cells using umbilical cord blood serum and a process for the preparation thereof for therapeutic purposes
DE10330216A1 (de) * 2003-07-03 2005-01-20 Jensen, Arne Wilhelm Oluf, Prof. Dr. Verwendung von Stammzellen aus Nabelschnurblut zur Verhinderung von Hirnschäden infolge Sauerstoffmangel und zur Neuroprotektion
KR100560340B1 (ko) * 2003-11-11 2006-03-14 한훈 제대혈로부터 중간엽 줄기세포의 분리 및 배양 방법
WO2005073366A1 (en) * 2004-01-30 2005-08-11 Lifecord Inc. Method for isolating and culturing multipotent progenitor/stem cells from umbilical cord blood and method for inducing differentiation thereof
KR100697326B1 (ko) * 2005-12-02 2007-03-20 재단법인서울대학교산학협력재단 Ｏｃｔ４ 발현능을 가지는 제대혈 유래 다분화능 성체줄기세포 및 그의 제조방법

Also Published As

Publication number Publication date
JP2007528229A (ja) 2007-10-11
WO2007024036A1 (en) 2007-03-01
ES2336230T3 (es) 2010-04-09
EP1807509A4 (de) 2008-08-20
EP1807509A1 (de) 2007-07-18
EP1807509B1 (de) 2009-11-18
US20070110727A1 (en) 2007-05-17
ATE449165T1 (de) 2009-12-15

Similar Documents

Publication Publication Date Title
DE602005017812D1 (de) Multipotente blutstammzellen aus der nabelschnur und zellbehandlungsmittel damit zur behandlung der ischämischen krankheit
WO2007024441A3 (en) Compositions of cells enriched for combinations of various stem and progenitor cell populations, methods of use thereof and methods of private banking thereof
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
EA201100441A1 (ru) Соединения для коррекции уровня мочевой кислоты и способы их применения
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA201000897A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
WO2007087367A3 (en) Methods and compositions for modulating the mobilization of stem cells
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
TR201903587T4 (tr) Telomeraz aktivitesinin artırılması için bileşimler.
TW200732347A (en) VEGF analogs and methods of use
WO2006050389A3 (en) Pyridazine compounds, compositions and methods
EA200800763A1 (ru) Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
NO20081212L (no) Xantinderivater som selektive HM74A agonister
EA200971053A1 (ru) Способы лечения кожных язв
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
WO2008089439A3 (en) Methods and compositions for enhancing lifespan involving sirtuin-modulating compounds and chalcogenides
MX2007004551A (es) Compuestos tiadiazol y metodos de uso.
MA28241A1 (fr) Derives d'indole hydroxyethylamine tricycliques et leur utilisation dans le traitement de la maladie d'alzheimer
TW200611695A (en) Pyrrolopyridine derivatives
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2007012057A3 (en) Vegetation water composition for treatment of inflammatory skin conditions
ATE473728T1 (de) Verwendung von fluoreszierenden perlylenverbindungen zur behandlung menschlicher haare

Legal Events

Date Code Title Description
8364 No opposition during term of opposition